Primaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases.

Conditions

• Vivax Malaria
• G6PD Deficiency

Interventions

• DRUG: Patients with G6PD enzyme activities between 30 and <70% of the AMM will be treated with schizontocidal treatment plus high dose primaquine 1mg/kg/day for 7 days
• DRUG: Patients with G6PD enzyme activities <30% of the AMM will be treated with schizontocidal treatment plus 8 weekly primaquine (0.75mg/kg dose).

Sponsor

Menzies School of Health Research

Collaborators

• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]